Expert second opinions for heart transplant evaluation. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Heart Transplant Evaluation s the gold standard treatment for end-stage heart failure, offering a median survival of 12-14 years. If you are facing a decision about heart transplant evaluation, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Heart transplantation remains the gold standard treatment for end-stage heart failure, offering a median survival of 12-14 years. Approximately 3,500 heart transplants are performed annually in the US. The evaluation process is extensive, including hemodynamic, immunologic, and psychosocial assessments.
Transplant listing decisions are among the most consequential in medicine. Some patients are deemed ineligible at one center but listed at another. Second opinions can identify reversible causes of heart failure, optimize medical therapy to delay or avoid transplant, or confirm transplant candidacy when there is uncertainty.
Surgery for heart transplant evaluation depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Transplant listing decisions are among the most consequential in medicine. Some patients are deemed ineligible at one center but listed at another. Second opinions can identify reversible causes of heart failure, optimize medical therapy to delay or avoid transplant, or confirm transplant candidacy when there is uncertainty.
Operative mortality for heart transplant evaluation-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for heart transplant evaluation depends on anatomy, comorbidities, age, and personal goals. Transplant candidacy and listing criteria. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.